A Randomized open label clinical trial for evaluation of efficacy and safety of Prazosin and Prazosin with scorpion anti- Venom combination in victims of venomous scorpion ( Mesobuthus Tamulus ) sting.

il0 个研究点目标入组 70 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients were eligible for enrollment if they reported to hospital with MT scorpion bite, with grade II, with an interval less than 6 hours between scorpion bite and hospitalization; age > 6 months. MT scorpion bite was confirmed if patient have seen red scorpion or brought the killed specimen or confirmed by showing him the hospital preserved specimen or photograph

•Major exclusion criteria were, patient reporting after six hours of sting, pregnant women, previous history of taking prazosin or scorpion Antivenom, patient with history of bronchial asthma or previous history of allergic reaction to foreign serum and who refused to give consent.

发起方